USE OF R(+)-ALPHA-LIPOIC ACID FOR CRYPTOGENIC NEUROPATHY

摘要

The present invention relates to the use of R(+)-alpha-lipoic acid ((R)-5-(1,2-dithiolan-3-yl)valeric acid) and/or of a physiologically acceptable derivative of this compound for cryptogenic neuropathy.